1. Market Research
  2. > Cancer Industry

Lymphoma Industry, February 2017 Market Reports from Top Publishers

You might be interested in: Diagnostics, Cancer, Therapy, Hematology Instrument, Pap Smear, Cancer Diagnostic, Cloud Computing, Leukemia, Transplantation, Lung Cancer, Blood Disease, Nuclear Imaging Equipment, Nuclear Medicine, Cancer Immunotherapy, Infectious Disease, Monoclonal Antibody, Specialty Hospital.


 
1-10 of about 300 reports for Lymphoma

Purchase Reports From Reputable Market Research Publishers

Global Hodgkin’s Lymphoma Therapeutics Market Research Report 2017

Global Hodgkin’s Lymphoma Therapeutics Market Research Report 2017

  • $ 2850
  • Industry report
  • February 2017
  • by 9Dimen Research

Hodgkin’s Lymphoma Therapeutics Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, ...

The Leukemia & Lymphoma Society Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Leukemia & Lymphoma Society Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2017
  • by GlobalData

Summary The Leukemia & Lymphoma Society Inc (LLS) is a healthcare center that offers blood cancer researches and funds raising services. The center’s services include patient services, health education, ...

Global Non-Hodgkin Lymphoma Therapeutics Market Research Report 2017

Global Non-Hodgkin Lymphoma Therapeutics Market Research Report 2017

  • $ 2850
  • Industry report
  • February 2017
  • by 9Dimen Research

Non-Hodgkin Lymphoma Therapeutics Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world’s major regional market conditions, ...

Global Lymphoma Partnering 2010 to 2017

Global Lymphoma Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies . Description The Global Lymphoma Partnering Terms and ...

Global Non-Hodgkin Lymphoma Partnering 2010 to 2017

Global Non-Hodgkin Lymphoma Partnering 2010 to 2017

  • $ 1495
  • Industry report
  • February 2017
  • by Currentpartnering

Summary Provides understanding and access to the non-hodgkin lymphoma partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global Non-Hodgkin Lymphoma ...

 Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Peripheral T-Cell ...

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2017

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Anaplastic ...

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Follicular Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III ...

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

  • $ 2000
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s Report, “Mantle Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Small lymphocytic lymphoma - Epidemiology Forecast To 2023

Small lymphocytic lymphoma - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Small lymphocytic lymphoma - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Small lymphocytic lymphoma in seven major markets (US, France, Germany, ...

About 5800 reports for Lymphoma

Download Unlimited Documents from Trusted Public Sources

Therapy Market and Lymphoma Statistics in the UK

  • July 2016
    182 pages
  • Therapy  

    Lymphoma  

    Chemotherapy  

  • United Kingdom  

View report >

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.